News
The program was formally launched July 28 at a signing ceremony at Wake Tech’s Beltline Education Center in Raleigh. Leaders ...
11h
Stockhead on MSNDr Boreham’s Crucible: Oncology-focused Qbiotics hopes to crawl through IPO ‘window of opportunity’With Virgin shares holding nicely at cruising altitude, is now the right time for private oncology drug developer Qbiotics to ...
GSK has moved to shore up its R&D pipeline with a strategic-level deal with China's Jiangsu Hengrui Pharma that spans a dozen drug candidates and could be worth up to $12.5 billion.
The agreement between Donald Trump, the US President, and Ursula von der Leyen, the President of the European Commission, on ...
During Brazil's COVID-19 vaccination campaign, when several brands of vaccines were available and the Chinese vaccine was the ...
11h
News-Medical.Net on MSNVaccine preferences found to be driven by national loyalty and trustThe country of origin effect is often observed in expensive or status-related products, such as wine and cars. Vaccines, on ...
The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD (metabolic dysfunction-associated steatotic liver disease – previously called ...
With the decline in UK public health campaign funding, we have explored the unique opportunity presented to the ...
Promising Ewing Sarcoma Pipeline Therapies such as Vigil, Temozolomide, Irinotecan, CP-751,871, Eribulin mesylate, ...
Pfizer has an analyst consensus of Moderate Buy, with a price target consensus of $28.40, which is a 13.7% upside from current levels. In a report issued on July 22, TR | OpenAI – 4o also downgraded ...
Apple’s pivot reveals a core truth: real innovation requires knowing whether you’re strength is in being able to dream it, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results